Overview
- Description
The company develops immune-cell therapies, using lactic acid bacteria as vectors to deliver biological drugs on-site to skin wounds or the GI tract.
- Website
- Country
- Sweden
- Sector
- Health Biotechnology
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.